Source: Virtual Congress 2021 – Holistic care in interstitial lung disease: monitoring the patient’s pathway



Rating:

Share or cite this content

Citations should be made in the following way:
E. Bendstrup (Aarhus N, Denmark). Living well with pulmonary fibrosis: new insights. Virtual Congress 2021 – Holistic care in interstitial lung disease: monitoring the patient’s pathway

Member's Comments

No comment yet.

Related content which might interest you: Role of MUC1 in idiopathic pulmonary fibrosis: mechanistic insights Source: International Congress 2017 – Idiopathic pulmonary fibrosis: from the bench to the bedside Year: 2017 Stress failure and high-altitude pulmonary oedema: mechanistic insights from physiology Source: Eur Respir J 2010; 35: 470-472 Year: 2010 Insights into idiopathic pulmonary fibrosis in the real world Source: Eur Respir J 2015; 46: 16-18 Year: 2015 Idiopathic pulmonary fibrosis: present understanding and future options Source: Eur Respir Rev 2011; 20: 132-133 Year: 2011 Pulmonary fibrosis: key features and challenges Source: International Congress 2015 – PG8 Airway and lung fibrosis Year: 2015 Multidisciplinary evaluation of interstitial lung diseases: current insights Source: Eur Respir Rev, 26 (144) 170002; 10.1183/16000617.0002-2017 Year: 2017 Novel insights into the pathogenesis of pulmonary arterial hypertension Source: Virtual Congress 2020 – Pulmonary vascular diseases Year: 2020 Novel insights into the genetics of smoking behaviour, lung function and chronic obstructive pulmonary disease in UK Biobank Source: International Congress 2015 – Asthma: emerging risk factors and current management of the patient Year: 2015 Lymphangiogenesis in chronic obstructive pulmonary disease (COPD): New insights in airways remodeling Source: Annual Congress 2010 - Airways and lung mechanics in subjects of all ages Year: 2010 Chronic cough: new insights and future prospects Source: Eur Respir Rev, 30 (162) 210127; 10.1183/16000617.0127-2021 Year: 2021 The pathogenesis of pulmonary fibrosis: a moving target Source: Eur Respir J 2013; 41: 1207-1218 Year: 2013 Combined pulmonary fibrosis and emphysema: A distinct entity? Source: Annual Congress 2012 - Idiopathic pulmonary fibrosis Year: 2012 Pulmonary Lymphangiomatosis – insights into an ultra-rare disease Source: International Congress 2018 – New insights in rare diffuse parenchymal lung diseases (DPLDs) in adults and children Year: 2018 Approach to pathogenetic treatment of experimental pulmonary fibrosis Source: Eur Respir J 2006; 28: Suppl. 50, 637s Year: 2006 Sildenafil for pulmonary hypertension complicating idiopathic pulmonary fibrosis: a rationale grounded in basic science Source: Eur Respir J 2016; 47:1615-1617 Year: 2016 Potential new biomarkers for idiopathic pulmonary fibrosis Source: Virtual Congress 2020 – Prognosis and biomarkers of idiopathic pulmonary fibrosis Year: 2020 Idiopathic pulmonary fibrosis: current challenges and future perspectives Source: Eur Respir Rev 2013; 22: 103-105 Year: 2013